The quiet $8 billion crisis: long COVID costs keep rising as Washington looks away
Long COVID continues to impose a significant economic burden on the United States, with an estimated cost exceeding $8 billion between 2025 and 2027. This persistent condition, characterized by lingering symptoms like fatigue and shortness of breath, affects millions of Americans and results in substantial productivity losses for employers. Despite the growing impact, federal funding for long COVID research has been cut, and specialized treatment clinics are scarce, leaving a gap in national strategy and effective management. AI
